COMMUNIQUÉS West-GlobeNewswire
-
FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease
02/07/2026 -
Vaxart Enters Cooperation Agreement with Stockholder Group and Announces Board and Corporate Governance Enhancements
01/07/2026 -
Fate Therapeutics to Participate in Upcoming Third Quarter 2026 Conferences
01/07/2026 -
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
01/07/2026 -
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/07/2026 -
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/07/2026 -
She Had No Clue, Until She Did: Clue's new campaign spotlights seven women who found the missing piece behind years of symptoms, questions and hormonal uncertainty
01/07/2026 -
Compass Health recognized as a Quasquicentennial Corporation, marking 125 Years of service in Northwest Washington
01/07/2026 -
FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients
01/07/2026 -
NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes
01/07/2026 -
How Meaningful Work Supports Long-Term Sobriety
01/07/2026 -
Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace
01/07/2026 -
Managing Mental Health During the Summer
01/07/2026 -
PolarityBio Announces Submission of its Biologics License Application for SkinTE® for the Treatment of Wagner Grade 1 Diabetic Foot Ulcers
01/07/2026 -
Applied Biologics Announces Expanded Strategic Focus on Surgical Applications of XWRAP®
01/07/2026 -
Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
01/07/2026 -
Correction: Abivax annonce la fixation du prix de l’Offre au public largement sursouscrite de 800 M$ (702 M€) d’American Depositary Shares
01/07/2026 -
Rentschler Biopharma appoints Dr. Torsten Woehr as Chief Executive Officer
01/07/2026 -
ORYZON Raises €12 Million and Signs a Financing Agreement with COFIDES to Strengthen its Balance Sheet and Accelerate its Clinical Programs
01/07/2026
Pages